Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

The Trump administration has started quietly rehiring some of the U.S. Food and Drug Administration employees it fired last week, according to nine agency sources, shortly after letting them go in a ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

The blistering rally in Hims & Hers Health Inc. that’s captivated meme-stock traders has ground to a halt, setting up a ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

That locked up the obesity drug. But after 9 Meters started ... Wegovy, for example, "doesn't really work" — at least to the Food and Drug Administration standard of weight loss of 5% or more ...